Matthias A. Karajannis, MD, MS - MSK ...

Dr. Matthias Karajannis, MD, MS

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Cerebral Gliomas
Studies Neurofibromatosis
6 reported clinical trials
10 drugs studied

Area of expertise

1Cerebral Gliomas
Matthias Karajannis, MD, MS has run 3 trials for Cerebral Gliomas. Some of their research focus areas include:
Stage IV
IDH negative
H3 K27M negative
2Neurofibromatosis
Matthias Karajannis, MD, MS has run 3 trials for Neurofibromatosis. Some of their research focus areas include:
NF2 positive
NF1 positive
Stage IV

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center

More about Matthias Karajannis, MD, MS

Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Matthias Karajannis, MD, MS has experience with
  • Temozolomide
  • Bevacizumab
  • Irinotecan
  • Omburtamab I-131
  • INCB7839
  • Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthias Karajannis, MD, MS specialize in?
Matthias Karajannis, MD, MS focuses on Cerebral Gliomas and Neurofibromatosis. In particular, much of their work with Cerebral Gliomas has involved Stage IV patients, or patients who are IDH negative.
Is Matthias Karajannis, MD, MS currently recruiting for clinical trials?
No, Matthias Karajannis, MD, MS is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Matthias Karajannis, MD, MS has studied deeply?
Yes, Matthias Karajannis, MD, MS has studied treatments such as Temozolomide, Bevacizumab, Irinotecan.
What is the best way to schedule an appointment with Matthias Karajannis, MD, MS?
Apply for one of the trials that Matthias Karajannis, MD, MS is conducting.
What is the office address of Matthias Karajannis, MD, MS?
The office of Matthias Karajannis, MD, MS is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security